Table 3 Overview of echocardiographic alterations in patients with CHD
From: Outcome of carcinoid heart syndrome in patients enrolled in the SwissNet cohort
|  | All patients, n = 23 | Group Aa, n = 4 | Group B, n = 12 | Group C, n = 6 |
|---|---|---|---|---|
Endocard Fibrosis, n (%) | ||||
 Yes | 4 (17) | 1 (25) | 1 (9) | 2 (33) |
 No | 14 (61) | 2 (50) | 8 (66) | 3 (50) |
 Not known | 5 (22) | 1 (25) | 3 (25) | 1 (17) |
Myocardial Decompensation, n (%) | ||||
 Yes | 6 (26) | 0 (0) | 3 (25) | 3 (50) |
 No | 14 (61) | 3 (75) | 8 (66) | 2 (33) |
 Not known | 3 (13) | 1 (25) | 1 (9) | 1 (17) |
Pulmonary Valve Stenosis, n (%) | ||||
 Yes | 6 (26) | 2 (50) | 2 (16) | 2 (33) |
 No | 13 (57) | 1 (25) | 7 (58) | 4 (67) |
 Not known | 4 (17) | 1 (25) | 3 (25) | 0 (0) |
Pulmonary Valve Insufficiency, n (%) | ||||
 Yes | 12 (52) | 3 (75) | 8 (75) | 1 (16) |
 No | 8 (35) | 1 (25) | 2 (12) | 4 (66) |
 Not known | 3 (13) | 0 (0) | 2 (12) | 1 (16) |
Tricuspid Valve Stenosis, n (%) | ||||
 Yes | 12 (52) | 2 (50) | 6 (50) | 4 (67) |
 No | 19 (39) | 1 (25) | 5 (41) | 2 (33) |
 Not known | 2 (9) | 1 (25) | 1 (9) | 0 (0) |
Tricuspid Valve Insufficiency, n (%) | ||||
 Yes | 22 (96) | 4 (100) | 12 (100) | 5 (83) |
 No | 1 (4) | 0 (0) | 0 (0) | 1 (17) |
 Not known | 0 (0) | 0 (0) | 0 (0) | 0 (0) |